FDA Recalls Calcium Acetate Capsules Due to Potential Labeling Errors
Aidapak Services, LLC is recalling Calcium Acetate capsules because they may be mislabeled as other medications. The repacked drugs were distributed in four western states.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported illnesses or injuries, fitting the criteria for minor labeling errors or low-risk contamination.
Plain-English summary
Aidapak Services, LLC is recalling Calcium Acetate, Capsule, 667 mg, Over The Counter, NDC 00054008826. The recall was initiated because the product may be potentially mislabeled as other drugs, including Zolpidem Tartrate, Acetazolamide, and Zinc Gluconate. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
The recall involves specific lots of Calcium Acetate capsules with expiration dates ranging from May 14, 2014, to June 20, 2014. The source text indicates a label mixup where the Calcium Acetate product may have been incorrectly identified as different pharmaceutical products.
Consumers who have purchased these specific lots of Calcium Acetate capsules should stop using the product and contact their pharmacist or healthcare provider for guidance. The recall is classified as FDA Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- CALCIUM ACETATE, Capsule, 667 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00054008826.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-The-Counter
- Hazard
- Affected units
- 3,600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- CALCIUM ACETATE
- Capsule
- 667 mg has the following codes: Pedigree:AD30180_1
- EXP: 5/8/2014
- Pedigree:AD62865_4
- EXP: 5/23/2014
- Pedigree:W003045
- EXP:6/12/2014
- Pedigree: AD52412_11
- EXP: 5/17/2014
- Pedigree: AD54587_1
- EXP: 5/21/2014
- Pedigree: AD62986_1
- Pedigree: AD73623_1
- EXP: 5/30/2014
- Pedigree: W003469
- EXP: 6/20/2014
- Pedigree: AD42592_1
- EXP: 5/14/2014
- Pedigree: AD52778_10
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02